Komori
Precision System Science (7707) · PolicyAchieved

Introduction of a Restricted Stock Compensation Plan

First written in FY2021. 2 of 5 entries say "Achieved", first in FY2022. Latest entry: FY2026-H1.

5entries
6years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseAdvancedFY2022-Q1 – FY20222021: 220212022: 120222023: 020232024: 020242025: 120252026: 1
Same theme, other companies
Grant and Issuance of Equity Compensation to Employees and Officers (Stock Options and Restricted Stock)A theme 654 companies write about · 0 as a headwind · 735 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 179 companies compared. The sentences above are computed from all 179.Comparing 200 of the theme's 737 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2026-H1AchievedAnnual report

    「Based on a resolution of the Board of Directors dated 26 September 2025, 270,000 treasury shares were disposed of as restricted stock compensation on 24 October 2025.」

    For the restricted stock compensation plan introduced and changed in FY2025, the disposal of 270,000 treasury shares through an in-kind contribution of ¥70,200 thousand was carried out on 24 October 2025.
  2. FY2025ReframedAnnual report

    「Subject to approval and adoption of the proposal concerning this plan at this General Meeting of Shareholders, the restricted stock compensation plan introduced at the 36th Annual General Meeting of Shareholders will be discontinued, and no further shares will be granted to directors under the plan.」

    The previous restricted stock compensation plan was discontinued and replaced with a one-time performance-based plan, conditional on returning to profitability and resuming dividend payments for the fiscal year ending June 2027.
  3. FY2022AchievedAnnual report

    「The breakdown of total non-monetary compensation, etc., for directors excluding outside directors was ¥71,537 thousand in restricted stock compensation.」

    For the restricted stock compensation plan introduced in the previous fiscal year, the grant of 116,700 treasury shares, with a total value of ¥71,537 thousand, to 5 Eligible Directors was recorded as compensation for the current fiscal year.
  4. FY2022-Q1AdvancedAnnual report

    「Disposal date: 5 November 2021; Class and number of shares to be disposed of: 116,700 common shares of the Company; Total disposal amount: ¥71,537 thousand; Proposed recipients: 5 directors of the Company, excluding outside directors, 116,700 shares」

    The specific implementation of the restricted stock compensation plan was approved, involving the disposal and allocation of 116,700 treasury shares with a total value of ¥71,537 thousand to 5 Eligible Directors.
  5. FY2021First statedAnnual report

    「In addition to monetary compensation, we provide the directors of the Company, excluding outside directors (hereinafter, the “Eligible Directors”), with non-monetary compensation consisting of grants of the Company’s common shares subject to specified transfer restriction periods and provisions for the Company’s gratis acquisition of the shares. The purpose is to provide incentives for improving business performance and sustainably increasing corporate value, while promoting greater value sharing with shareholders.」

    In addition to the existing fixed and performance-linked compensation, a restricted stock compensation plan was introduced to improve business performance and share value with shareholders. The funding is limited to 10% or less of consolidated net income for the period and ¥100 million or less in total.
Moved together

"Dependence of sales on the automated DNA extraction system" moved the same way as this thread, in the same document, in 4 of its 5 moves.

432222★123456
  1. ★This thread
  2. 1Dependence of sales on the automated DNA extraction system4×
  3. 2Recurring Losses, Negative Operating Cash Flow and an Early Return to Profitability3×
  4. 3Expansion from an equipment-centered business into the reagent and diagnostic reagent businesses2×
  5. 4Coexistence of the OEM Business and In-House Sales2×
  6. 5Establishing a Profitable Structure for the Fiscal Year Ending June 20242×
  7. 6Foreign exchange fluctuation risk arising from the scale of overseas sales2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Precision System Science yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Introduction of a Restricted Stock Compensation Plan | Precision System Science Co.,Ltd. (7707) | Komori